Clinical Trial Update: Adjunctive Esketamine for Analgesia in Mechanically Ventilated Septic Shock Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating adjunctive esketamine for analgesia in mechanically ventilated septic shock patients is in progress with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mechanical Ventilation Complication
• Septic Shock

Drugs mentioned

• Esketamine (esketamine)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Septic Shock, Mechanical Ventilation Complication | Phase 3 | Status: UNKNOWN